Syneron Medical Ltd. was a prominent global company specializing in the development, manufacturing, and marketing of aesthetic medical devices. Founded in 2000 and headquartered in Israel, Syneron was recognized for its innovative technologies, including the proprietary elōs (electro-optical synergy) platform, which combined optical energy with radiofrequency for various aesthetic treatments such as hair removal, skin rejuvenation, wrinkle reduction, and body contouring. Syneron acquired Candela Corporation in 2010, operating under the Syneron Candela brand for several years. The company had a significant global presence before being acquired by Apax Partners-backed Candela Corporation in 2017, subsequently becoming part of what is now Candela Medical.
Served as the central hub for research and development, global corporate strategy, manufacturing oversight, and administrative operations for Syneron's aesthetic medical device business.
The facility likely housed state-of-the-art R&D laboratories for energy-based device development, possibly clean rooms for medical device assembly, and modern office spaces supporting global operations within Israel's 'Silicon Wadi' tech ecosystem.
The work culture at Syneron's Yokneam headquarters was likely dynamic and innovation-focused, characteristic of Israeli high-tech and medical device companies. It probably emphasized R&D excellence, collaboration between engineering and medical professionals, and a drive to bring cutting-edge aesthetic solutions to the global market.
The Yokneam Illit headquarters was crucial as the birthplace of Syneron's core innovative technologies, including elōs, and acted as the command center for its worldwide operations, underscoring Israel's strong presence in the medical device industry.
Prior to its 2017 acquisition, Syneron Medical maintained a robust global presence, supporting its operations through a network of direct sales offices and distributors in over 80 countries. This worldwide infrastructure facilitated sales, marketing initiatives, clinical training programs, and comprehensive technical support for its extensive portfolio of aesthetic medical devices, effectively reaching medical practitioners and their patients across North America, Europe, Asia-Pacific, Latin America, and other international markets.
Tavor Building, Sha'ar Yokneam, P.O. Box 550
Yokneam Illit
Northern District
Israel
Address: 3 Goodyear, Suite B, Irvine, CA 92618, USA (as Syneron Candela North America HQ)
To manage and expand Syneron's market presence in the significant North American aesthetic device market, providing localized support and services to clinicians and partners.
Address: Kasteler Str. 45, 65203 Wiesbaden, Germany (Syneron Deutschland GmbH)
To strengthen Syneron's foothold in the European market, catering to the specific needs of aesthetic practitioners and clinics in the region with local expertise and support.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Syneron Candela' leadership includes:
Syneron Candela has been backed by several prominent investors over the years, including:
As Syneron Medical Ltd. (operating as Syneron Candela) was acquired by Candela Corporation (backed by Apax Partners) in mid-2017, the most significant executive changes involved the departure of Syneron's top leadership as part of the integration. New appointments were primarily for the newly structured, combined Candela entity rather than Syneron Medical in its final standalone phase.
Discover the tools Syneron Candela uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While specific historical email formats for Syneron Medical are not publicly documented, global technology companies of its nature commonly used standardized formats based on employee names, typically with the domain @syneron.com.
[first].[last]@syneron.com or [first_initial][last]@syneron.com (estimated historical formats)
Format
john.doe@syneron.com or jdoe@syneron.com (example patterns)
Example
60%
Success rate
PR Newswire • July 17, 2017
Candela Corporation, a leading global medical aesthetic device company (at the time owned by Apax Partners), announced the successful completion of its acquisition of Syneron Medical Ltd. (which was operating as Syneron Candela). The acquisition aimed to create a market leader in medical aesthetic devices....more
GlobeNewswire • October 29, 2014
Syneron Medical Ltd. (NASDAQ:ELOS), a global market leader in the aesthetic medical device marketplace, announced that it received FDA clearance and European CE mark approval for the PicoWay® picosecond laser, designed for tattoo removal and treatment of pigmented lesions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Syneron Candela, are just a search away.